- Home
- PGC vs AUTL Comparison
PGC vs AUTL Comparison
Compare PGC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGC | AUTL |
|---|---|---|
| Founded | 1921 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.1M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PGC | AUTL |
|---|---|---|
| Price | $29.51 | $1.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $35.33 | $8.33 |
| AVG Volume (30 Days) | 92.4K | ★ 2.6M |
| Earning Date | 01-26-2026 | 11-12-2025 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | ★ 6.12 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $248,809,000.00 | $51,128,000.00 |
| Revenue This Year | $27.34 | $672.42 |
| Revenue Next Year | $16.59 | $84.48 |
| P/E Ratio | $15.31 | ★ N/A |
| Revenue Growth | 18.63 | ★ 406.67 |
| 52 Week Low | $23.96 | $1.11 |
| 52 Week High | $35.41 | $2.70 |
Technical Indicators
Market Signals| Indicator | PGC | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 54.90 | 42.42 |
| Support Level | $28.69 | $1.33 |
| Resistance Level | $31.62 | $1.56 |
| Average True Range (ATR) | 0.91 | 0.13 |
| MACD | 0.16 | -0.04 |
| Stochastic Oscillator | 47.43 | 16.06 |
Price Performance
Historical ComparisonAbout PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.